Search

David Guzo

Examiner (ID: 2124)

Most Active Art Unit
1636
Art Unit(s)
1805, 1636, 2899
Total Applications
1205
Issued Applications
693
Pending Applications
160
Abandoned Applications
352

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6361371 [patent_doc_number] => 20020058637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Methods of inhibiting tau-protein kinase I activity, inhibiting neuronal cell death and treating alzheimer\'s disease and tau-protein kinase I' [patent_app_type] => new [patent_app_number] => 09/866712 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8975 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058637.pdf [firstpage_image] =>[orig_patent_app_number] => 09866712 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/866712
Methods of inhibiting tau-protein kinase I activity, inhibiting neuronal cell death and treating alzheimer's disease and tau-protein kinase I May 29, 2001 Abandoned
Array ( [id] => 5726793 [patent_doc_number] => 20060057553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Chimeric viral vectors for gene therapy' [patent_app_type] => utility [patent_app_number] => 10/297341 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30191 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057553.pdf [firstpage_image] =>[orig_patent_app_number] => 10297341 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/297341
Chimeric viral vectors for gene therapy May 29, 2001 Abandoned
09/856659 Novel packaging cell line for the rescue, production and titration of high-capacity adenovirus amplicon vectors May 22, 2001 Abandoned
Array ( [id] => 5016220 [patent_doc_number] => 20070259429 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2007-11-08 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => utility [patent_app_number] => 09/860211 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16583 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0259/20070259429.pdf [firstpage_image] =>[orig_patent_app_number] => 09860211 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/860211
Adenoviral vectors having a protein IX deletion May 17, 2001 Abandoned
Array ( [id] => 6860526 [patent_doc_number] => 20030091534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => new [patent_app_number] => 09/860286 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16752 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091534.pdf [firstpage_image] =>[orig_patent_app_number] => 09860286 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/860286
Adenoviral vectors having a protein IX deletion May 17, 2001 Abandoned
Array ( [id] => 5016220 [patent_doc_number] => 20070259429 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2007-11-08 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => utility [patent_app_number] => 09/860211 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16583 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0259/20070259429.pdf [firstpage_image] =>[orig_patent_app_number] => 09860211 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/860211
Adenoviral vectors having a protein IX deletion May 17, 2001 Abandoned
Array ( [id] => 6860526 [patent_doc_number] => 20030091534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => new [patent_app_number] => 09/860286 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16752 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091534.pdf [firstpage_image] =>[orig_patent_app_number] => 09860286 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/860286
Adenoviral vectors having a protein IX deletion May 17, 2001 Abandoned
Array ( [id] => 1439342 [patent_doc_number] => 06495132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-17 [patent_title] => 'Method for producing polypeptides' [patent_app_type] => B2 [patent_app_number] => 09/859773 [patent_app_country] => US [patent_app_date] => 2001-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6544 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495132.pdf [firstpage_image] =>[orig_patent_app_number] => 09859773 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/859773
Method for producing polypeptides May 16, 2001 Issued
09/600766 Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein May 13, 2001 Abandoned
Array ( [id] => 6711564 [patent_doc_number] => 20030171313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Compositions and methods for treatment of hepatitis C virus-associated diseases' [patent_app_type] => new [patent_app_number] => 09/853409 [patent_app_country] => US [patent_app_date] => 2001-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13101 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171313.pdf [firstpage_image] =>[orig_patent_app_number] => 09853409 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/853409
Compositions and methods for treatment of hepatitis C virus-associated diseases May 10, 2001 Issued
Array ( [id] => 6594421 [patent_doc_number] => 20020042134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Modification of bacteria' [patent_app_type] => new [patent_app_number] => 09/851419 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8422 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042134.pdf [firstpage_image] =>[orig_patent_app_number] => 09851419 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/851419
Modification of bacteria May 8, 2001 Issued
Array ( [id] => 7015052 [patent_doc_number] => 20010051605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'Epidermal growth factor inhibitor' [patent_app_type] => new [patent_app_number] => 09/850373 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6903 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051605.pdf [firstpage_image] =>[orig_patent_app_number] => 09850373 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/850373
Epidermal growth factor inhibitor May 6, 2001 Abandoned
Array ( [id] => 7363878 [patent_doc_number] => 20040091866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation' [patent_app_type] => new [patent_app_number] => 10/258930 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7523 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091866.pdf [firstpage_image] =>[orig_patent_app_number] => 10258930 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/258930
Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation Apr 29, 2001 Issued
Array ( [id] => 6947890 [patent_doc_number] => 20010021524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Viral-mediated gene transfer system' [patent_app_type] => new [patent_app_number] => 09/842941 [patent_app_country] => US [patent_app_date] => 2001-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6653 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021524.pdf [firstpage_image] =>[orig_patent_app_number] => 09842941 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/842941
Viral-mediated gene transfer system Apr 25, 2001 Abandoned
Array ( [id] => 7459906 [patent_doc_number] => 20040052764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids' [patent_app_type] => new [patent_app_number] => 10/257961 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13551 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20040052764.pdf [firstpage_image] =>[orig_patent_app_number] => 10257961 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/257961
Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids Apr 22, 2001 Issued
Array ( [id] => 1172080 [patent_doc_number] => 06750043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-15 [patent_title] => 'Viral vectors having reduced virulence' [patent_app_type] => B2 [patent_app_number] => 09/837998 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2137 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750043.pdf [firstpage_image] =>[orig_patent_app_number] => 09837998 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/837998
Viral vectors having reduced virulence Apr 18, 2001 Issued
Array ( [id] => 6893981 [patent_doc_number] => 20010016347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-23 [patent_title] => 'Non-primate lentiviral vectors and packaging systems' [patent_app_type] => new [patent_app_number] => 09/837644 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23292 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20010016347.pdf [firstpage_image] =>[orig_patent_app_number] => 09837644 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/837644
Lentiviral nucleic acids and uses thereof Apr 16, 2001 Issued
Array ( [id] => 6032855 [patent_doc_number] => 20020019031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Chinese hamster ovary cells for producing proteins' [patent_app_type] => new [patent_app_number] => 09/835089 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3200 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019031.pdf [firstpage_image] =>[orig_patent_app_number] => 09835089 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/835089
Chinese hamster ovary cells for producing proteins Apr 12, 2001 Abandoned
Array ( [id] => 5786927 [patent_doc_number] => 20020160357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Differentiation of avian infectious bronchitis virus serotypes' [patent_app_type] => new [patent_app_number] => 09/829250 [patent_app_country] => US [patent_app_date] => 2001-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7782 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160357.pdf [firstpage_image] =>[orig_patent_app_number] => 09829250 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/829250
Differentiation of avian infectious bronchitis virus serotypes Apr 8, 2001 Abandoned
Array ( [id] => 6884676 [patent_doc_number] => 20010038836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-08 [patent_title] => 'Application of myeloid-origin cells to the nervous system' [patent_app_type] => new [patent_app_number] => 09/825713 [patent_app_country] => US [patent_app_date] => 2001-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 7854 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20010038836.pdf [firstpage_image] =>[orig_patent_app_number] => 09825713 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/825713
Application of myeloid-origin cells to the nervous system Apr 3, 2001 Abandoned
Menu